Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Novel CD22 CAR-T therapy for paediatric leukaemia
Dr Jing Pan - Beijing Boren Hospital, Beijing, China
Novel CD22 CAR-T therapy for paediatric leukaemia ( Dr Jing Pan - Beijing Boren Hospital, Beijing, China )
16 Jun 2018
Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma
Dr Ramon Garcia Sanz - Hospital Universitario de Salamanca, Salamanca, Spain
Brentuximab vedotin with chemo for relapsed Hodgkin lymphoma ( Dr Ramon Garcia Sanz - Hospital Universitario de Salamanca, Salamanca, Spain )
16 Jun 2018
EHA 2018: Research, collaboration and working towards cures
Prof Pieter Sonneveld - Erasmus MC, Rotterdam, Holland
EHA 2018: Research, collaboration and working towards cures ( Prof Pieter Sonneveld - Erasmus MC, Rotterdam, Holland )
16 Jun 2018
Educational focus on immunotherapy at EHA
Prof John Gribben - Barts Cancer Institute, London, United Kingdom
Educational focus on immunotherapy at EHA ( Prof John Gribben - Barts Cancer Institute, London, United Kingdom )
16 Jun 2018
A new anti-CD22 CAR T immunotherapy for paediatric leukaemia
Dr Jing Pan - Beijing Boren Hospital, Beijing, China
A new anti-CD22 CAR T immunotherapy for paediatric leukaemia ( Dr Jing Pan - Beijing Boren Hospital, Beijing, China )
16 Jun 2018
EHA Topics in focus : Immunotherapy
Prof John Gribben - Barts Cancer Institute, London, United Kingdom
EHA Topics in focus : Immunotherapy ( Prof John Gribben - Barts Cancer Institute, London, United Kingdom )
16 Jun 2018
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma
Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina
Emerging post-transplant therapeutic options for relapsed Hodgkin lymphoma ( Dr Astrid Pavlovsky - Center for Haematology, Buenos Aires, Argentina )
15 Jun 2018
Rituximab in combination therapies for FL: Interim results
Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France
Rituximab in combination therapies for FL: Interim results ( Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France )
15 Jun 2018
Improved OS with obinutuzumab in the CLL11 study
Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany
Improved OS with obinutuzumab in the CLL11 study ( Dr Valentin Goede - St. Marien-Hospital, Cologne, Germany )
15 Jun 2018
Disease control in advanced Hodgkin lymphoma
Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Disease control in advanced Hodgkin lymphoma ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018
Interim results of RELEVANCE trial in follicular lymphoma
Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France
Interim results of RELEVANCE trial in follicular lymphoma ( Prof Franck Morschhauser - Hôpital Claude Huriez, Lille, France )
15 Jun 2018
Update on bb2121 for relapsed myeloma
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Update on bb2121 for relapsed myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
15 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation